Glaucoma Surgery Devices (Ophthalmic Devices) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Glaucoma Surgery Devices (Ophthalmic Devices) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)
Summary
Glaucoma Surgery Devices (Ophthalmic Devices) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within Ophthalmic Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Glaucoma Surgery Devices market for the year 2020 and beyond. Aging population coupled with increase in incidence and prevalence of glaucoma globally is the leading cause of irreversible vision loss, and best preventive measure to stop the irreversible vision loss is drainage of fluids from the eyes. This is expected to increase sales of valved and non-valved drainage devices.
Glaucoma Surgery Devices have a long history of use in the US and European markets and are well established in emerging markets such as APAC and South America.
Each of the covered 39 countrys color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Glaucoma Surgery Devices and evolving competitive landscape -
- Insightful review of the key industry trends.
- Annualized total Glaucoma Surgery Devices market revenue by segment and market outlooks from 2015-2030.
- Granular data on total procedures, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights -
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
- SWOT analysis for Glaucoma Surgery Devices market.
- Competitive dynamics insights and trends provided for Venous Stents market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Aurolab, Alcon Inc., Molteno Ophthalmic Limited, Jhonson & Johnson, iStar Medical, New World Medicals, Glaukos Corporation, Ivantis, Allergan Inc., Santen Pharmaceutical Co., Ltd., Sight Sciences, Novaeye Medical, D.O.R.C. International B.V
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
Scope
This Market Model gives important, expert insight you wont find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
- CMO executives who must have deep understanding of the Glaucoma Surgery Devices marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to -
- Understand the impact of COVID-19 on Glaucoma Surgery Devices.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving Glaucoma Surgery Devices.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Glaucoma Surgery Devices market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific Glaucoma Surgery Devices market from 2015-2030.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Summary
Glaucoma Surgery Devices (Ophthalmic Devices) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within Ophthalmic Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Glaucoma Surgery Devices market for the year 2020 and beyond. Aging population coupled with increase in incidence and prevalence of glaucoma globally is the leading cause of irreversible vision loss, and best preventive measure to stop the irreversible vision loss is drainage of fluids from the eyes. This is expected to increase sales of valved and non-valved drainage devices.
Glaucoma Surgery Devices have a long history of use in the US and European markets and are well established in emerging markets such as APAC and South America.
Each of the covered 39 countrys color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Glaucoma Surgery Devices and evolving competitive landscape -
- Insightful review of the key industry trends.
- Annualized total Glaucoma Surgery Devices market revenue by segment and market outlooks from 2015-2030.
- Granular data on total procedures, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights -
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
- SWOT analysis for Glaucoma Surgery Devices market.
- Competitive dynamics insights and trends provided for Venous Stents market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Aurolab, Alcon Inc., Molteno Ophthalmic Limited, Jhonson & Johnson, iStar Medical, New World Medicals, Glaukos Corporation, Ivantis, Allergan Inc., Santen Pharmaceutical Co., Ltd., Sight Sciences, Novaeye Medical, D.O.R.C. International B.V
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
Scope
This Market Model gives important, expert insight you wont find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
- CMO executives who must have deep understanding of the Glaucoma Surgery Devices marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to -
- Understand the impact of COVID-19 on Glaucoma Surgery Devices.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving Glaucoma Surgery Devices.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Glaucoma Surgery Devices market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific Glaucoma Surgery Devices market from 2015-2030.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
TABLE OF CONTENTS
Not Applicable
List Of Tables
Not ApplicableList Of Figures
Not ApplicableRELATED REPORTS
Open-Angle Glaucoma (OAG) - Market Insights, Competitive Landscape and Market Forecast–2026
DelveInsights Open-Angle Glaucoma (OAG) Market Insights, Competitive Landscape and Market Forecast-2026 report delivers an in-depth understanding of open-angle glaucoma and the historical and forecasted open-angle glaucoma market trends in the
View ReportGlobal Micro-Invasive Glaucoma Surgery Devices Market Research Report 2021-2025
In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Micro-Invasive Glaucoma Surgery Devices Report by Material, Application,
View ReportGlobal Vitreoretinal Surgery Devices Market 2023
DescriptionThe Vitreoretinal Surgery Devices Market is anticipated to witness substantial growth, with a projected increase from USD 1.49 billion in 2022 to USD 1.85 billion by 2029. This growth is
View ReportGlobal Ophthalmology Surgery Devices Market Research Report 2023-2027
Ophthalmology surgery devices are used for studying, diagnosing, and treating ocular disorders. Eyes are sensory organs, which need protection from inflammation, infection, and trauma to maintain a normal vision. In
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
